Waverton Investment Management LTD Abb Vie Inc. Transaction History

Waverton Investment Management LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $770,204 - $963,689	-10,678 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $90,376 - $108,658	-1,435 Reduced 11.85%	10,678 $809,000
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $27,265 - $34,851	415 Added 3.55%	12,113 $881,000
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $19,439 - $22,879	252 Added 2.2%	11,698 $943,000
Q4 2018 Jan 14, 2019	BUY	$77.85 - $96.01 $49,512 - $61,062	636 Added 5.88%	11,446 $1.06 Million
Q3 2018 Oct 04, 2018	SELL	$88.91 - $98.84 $173,374 - $192,738	-1,950 Reduced 15.28%	10,810 $1.02 Million
Q2 2018 Aug 22, 2018	BUY	$89.78 - $106.23 $1.14 Million - $1.35 Million	12,667 Added 13620.43%	12,760 $0
Q2 2018 Aug 21, 2018	SELL	$89.78 - $106.23 $1.16 Million - $1.38 Million	-12,951 Reduced 99.29%	93 $13,000
Q1 2018 Apr 06, 2018	BUY	$92.01 - $123.21 $43,336 - $58,031	471 Added 3.75%	13,044 $1.24 Million
Q4 2017 Jan 10, 2018	BUY	$89.56 - $98.21 $181,985 - $199,562	2,032 Added 19.28%	12,573 $1.22 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $736,288 - $940,468	10,541	10,541 $937,000

3,850

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $311B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Waverton Investment Management LTD with notifications on news.